Open Access
Article

Estrous cycle phase affects myocardial infarction through reactive oxygen species and nitric oxide

Diana Ramírez-Hernández1,2,Pedro López-Sanchez2,Martha C. Rosales-Hernández3, Salvador Fonseca-Coronado1,Jazmín Flores-Monroy1,*
1
Laboratorio de Farmacologia del Miocardio, Facultad de Estudios Superiores Cuautitlan, Universidad Nacional Autonoma de Mexico, 54740 Estado de México, México
2
Laboratorio de Farmacologia Molecular, Escuela Superior de Medicina, Instituto Politecnico Nacional, 11340 Ciudad de México, México
3
Laboratorio de Biofísica y Biocatalisis, Seccion de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politecnico Nacional, 11340 Ciudad de México, México
DOI: 10.52586/5037 Volume 26 Issue 12, pp.1434-1443
Submited: 14 April 2021 Revised: 27 August 2021
Accepted: 23 September 2021 Published: 30 December 2021
*Corresponding Author(s):  
Jazmín Flores-Monroy
E-mail:  
jfmqfb@gmail.com
Copyright: © 2021 The author(s). Published by BRI. This is an open access article under the CC BY 4.0 license (https://creativecommons.org/licenses/by/4.0/).
Abstract

Introduction: Myocardial infarction is the leading cause of death in women worldwide. Several studies have shown that estrogens play a cardioprotective role in women by decreasing reactive oxygen species (ROS) and increasing nitric oxide (NO). The aim of this work was to determine whether the evolution of myocardial infarction depends on the phase of the estrous cycle. Methods: Female Wistar rats were randomized into the following groups with an (n = 7 per group): (1) ovariectomized (OVX-sham); (2) OVX-48 h coronary occlusion (CO); (3) OVX-2 w CO; (4) proestrus-sham; (5) proestrus-48 h CO; (6) proestrus-2 w CO; (7) estrus-sham; (8) estrus-48 h CO; and (9) estrus-2 w CO. We measured the percentage of myocardial necrosis, cardiac hypertrophy, hemodynamic parameters, and the production of NO and ROS, after acute and chronic myocardial infarction was induced in proestrus or estrus or ovariectomized female rats. Results: The infarct area was reduced in the proestrus groups, while it was increased in the estrus and OVX groups. The left ventricular systolic pressure (LVSP) and ±± dP/dt were reduced, but left ventricular diastolic pressure (LVDP) was increased in the OVX groups. NO was increased in the OVX + CO and estrus + CO groups. Production of ROS was increased in OVX rats after myocardial infarction but remained unchanged in proestrus and estrus. Conclusion: The phase of the estrous cycle in which the myocardial infarction occurs is important. When the coronary occlusion occurs during the proestrus phase, it prevents changes in cardiac function, the development of hypertrophy, oxidative stress and changes in NO levels, and reduces the extent of infarction.

Key words

Estrous cycle; Reactive oxygen species; Nitric oxide; Myocardial infarction

References

[1] Mehta LS, Beckie TM, DeVon HA, Grines CL, Krumholz HM, Johnson MN, et al. Acute Myocardial Infarction in Women: A Scientific Statement From the American Heart Association. Circulation. 2016; 133: 916–947.

[2] Regitz-Zagrosek V. Unsettled Issues and Future Directions for Research on Cardiovascular Diseases in Women. Korean Circulation Journal. 2018; 48: 792–812.

[3] Coughlin SS. Epidemiology of Breast Cancer in Women. Advances in Experimental Medicine and Biology. 2019; 1152: 9–29.

[4] Sharma S, Wood MJ. The Global Burden of Cardiovascular Disease in Women. Current Treatment Options in Cardiovascular Medicine. 2018; 20: 81.

[5] Iorga A, Cunningham CM, Moazeni S, Ruffenach G, Umar S, Eghbali M. The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy. Biology of Sex Differences. 2017; 8: 33.

[6] Mukamal KJ, Muller JE, Maclure M, Sherwood JB, Mittleman MA. Variation in the risk of onset of acute myocardial infarction during the menstrual cycle. The American Journal of Cardiology. 2002; 90: 49–51.

[7] Henderson BE, Paganini-Hill A, Ross RK. Estrogen replacement therapy and protection from acute myocardial infarction. American Journal of Obstetrics and Gynecology. 1988; 159: 312–317.

[8] Rosenberg L. Noncontraceptive estrogens and myocardial infarction in young women. The Journal of the American Medical Association. 1980; 244: 339–342.

[9] Rosenberg L, Armstrong B, Jick H. Myocardial infarction and estrogen therapy in post-menopausal women. The New England Journal of Medicine. 1976; 294: 1256–1259.

[10] Psaty BM, Heckbert SR, Atkins D, Lemaitre R, Koepsell TD, Wahl PW, et al. The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women. Archives of Internal Medicine. 1994; 154: 1333–1339.

[11] Benn M, Voss SS, Holmegard HN, Jensen GB, Tybjærg-Hansen A, Nordestgaard BG. Extreme concentrations of endogenous sex hormones, ischemic heart disease, and death in women. Arteriosclerosis, Thrombosis, and Vascular Biology. 2015; 35: 471–477.

[12] Clegg D, Hevener AL, Moreau KL, Morselli E, Criollo A, Van Pelt RE, et al. Sex Hormones and Cardiometabolic Health: Role of Estrogen and Estrogen Receptors. Endocrinology. 2017; 158: 1095–1105.

[13] Zhan Y, Liu Z, Li M, Ding T, Zhang L, Lu Q, et al. ERβ expression in the endothelium ameliorates ischemia/reperfusionmediated oxidative burst and vascular injury. Free Radical Biology & Medicine. 2016; 96: 223–233.

[14] Muka T, Vargas KG, Jaspers L, Wen K, Dhana K, Vitezova A, et al. Estrogen receptor β actions in the female cardiovascular system: a systematic review of animal and human studies. Maturitas. 2016; 86: 28–43.

[15] Lee T, Lin M, Chou T, Tsai C, Chang N. Adjunctive 17betaestradiol administration reduces infarct size by altered expression of canine myocardial connexin43 protein. Cardiovascular Research. 2004; 63: 109–117.

[16] Junjie X. Exercise for Cardiovascular Disease Prevention and Treatment. Springer: Singapore. 2017.

[17] Schulz R, Kelm M, Heusch G. Nitric oxide in myocardial ischemia/ reperfusion injury. Cardiovascular Research. 2004; 61: 402–413.

[18] Massion PB, Feron O, Dessy C, Balligand J. Nitric oxide and cardiac function: ten years after, and continuing. Circulation Research. 2003; 93: 388–398.

[19] Ray PD, Huang B, Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cellular Signalling. 2012; 24: 981–990.

[20] Rico H, Valencia MJ, Villa LF, Hernández ER, Seco C, Sánchez-Atrio A, et al. Calcitonin versus clodronate in the prevention of ovariectomy-induced osteopenia in rats. Clinical Rheumatology. 2000; 19: 47–50.

[21] Marcondes FK, Bianchi FJ, Tanno AP. Determination of the estrous cycle phases of rats: some helpful considerations. Brazilian Journal of Biology. 2002; 62: 609–614.

[22] Flores-Monroy J, Ferrario CM, Valencia-Hernández I, Hernández-Campos ME, Martínez-Aguilar L. Comparative effects of a novel angiotensin-converting enzyme inhibitor versus captopril on plasma angiotensins after myocardial infarction. Pharmacology. 2014; 94: 21–28.

[23] Zimmer H-, Zierhut W, Seesko RC, Varekamp AE. Right heart catheterization in rats with pulmonary hypertension and right ventricular hypertrophy. Basic Research in Cardiology. 1988; 83: 48–57.

[24] Hensley K. Nitrite Determination by Colorimetric and Fluorometric Griess Diazotization Assays [Protocol]. Humana Press: Totowa. 2003.

[25] Dikalov SI, Polienko YF, Kirilyuk I. Electron Paramagnetic Resonance Measurements of Reactive Oxygen Species by Cyclic Hydroxylamine Spin Probes. Antioxidants & Redox Signaling. 2018; 28: 1433–1443.

[26] Aryan L, Younessi D, Zargari M, Banerjee S, Agopian J, Rahman S, et al. The Role of Estrogen Receptors in Cardiovascular Disease. International Journal of Molecular Sciences. 2020; 21: 4314.

[27] Deschamps AM, Murphy E, Sun J. Estrogen receptor activation and cardioprotection in ischemia reperfusion injury. Trends in Cardiovascular Medicine. 2010; 20: 73–78.

[28] Kallen AN, Pal L. Cardiovascular disease and ovarian function. Current Opinion in Obstetrics & Gynecology. 2011; 23: 258–267.

[29] Naftolin F, Friedenthal J, Nachtigall R, Nachtigall L. Cardiovascular health and the menopausal woman: the role of estrogen and when to begin and end hormone treatment. F1000Research. 2019; 8: F1000

[30] Oliver-Williams C, Glisic M, Shahzad S, Brown E, Pellegrino Baena C, Chadni M, et al. The route of administration, timing, duration and dose of postmenopausal hormone therapy and cardiovascular outcomes in women: a systematic review. Human Reproduction Update. 2019; 25: 257–271.

[31] He Z, He YJ, Day AL, Simpkins JW. Proestrus levels of estradiol during transient global cerebral ischemia improves the histological outcome of the hippocampal CA1 region: perfusiondependent and-independent mechanisms. Journal of the Neurological Sciences. 2002; 193: 79–87.

[32] Butcher RL, Collins WE, Fugo NW. Plasma concentration of LH, FSH, prolactin, progesterone and estradiol-17beta throughout the 4-day estrous cycle of the rat. Endocrinology. 1974; 94: 1704–1708.

[33] Booth EA, Marchesi M, Knittel AK, Kilbourne EJ, Lucchesi BR. The pathway-selective estrogen receptor ligand WAY-169916 reduces infarct size after myocardial ischemia and reperfusion by an estrogen receptor dependent mechanism. Journal of Cardiovascular Pharmacology. 2007; 49: 401–407.

[34] Dworatzek E, Mahmoodzadeh S. Targeted basic research to highlight the role of estrogen and estrogen receptors in the cardiovascular system. Pharmacological Research. 2017; 119: 27–35.

[35] Pelzer T, Schumann M, Neumann M, deJager T, Stimpel M, Serfling E, et al. 17beta-estradiol prevents programmed cell death in cardiac myocytes. Biochemical and Biophysical Research Communications. 2000; 268: 192–200.

[36] van Eickels M, Patten RD, Aronovitz MJ, Alsheikh-Ali A, Gostyla K, Celestin F, et al. 17-beta-estradiol increases cardiac remodeling and mortality in mice with myocardial infarction. Journal of the American College of Cardiology. 2003; 41: 2084–2092.

[37] Schubert C, Raparelli V, Westphal C, Dworatzek E, Petrov G, Kararigas G, et al. Reduction of apoptosis and preservation of mitochondrial integrity under ischemia/reperfusion injury is mediated by estrogen receptor β. Biology of Sex Differences. 2016; 7: 53.

[38] Klinge CM. Estrogens regulate life and death in mitochondria. Journal of Bioenergetics and Biomembranes. 2017; 49: 307–324.

[39] Zhou Z, Ribas V, Rajbhandari P, Drew BG, Moore TM, Fluitt AH, et al. Estrogen receptor α protects pancreatic β-cells from apoptosis by preserving mitochondrial function and suppressing endoplasmic reticulum stress. The Journal of Biological Chemistry. 2018; 293: 4735–4751.

[40] Almeida SAD, Claudio ERG, Mengal V, Mengal VF, Oliveira SGD, Merlo E, et al. Exercise training reduces cardiac dysfunction and remodeling in ovariectomized rats submitted to myocardial infarction. PLoS ONE. 2014; 9: e115970.

[41] Pinkham MI, Whalley GA, Guild S, Malpas SC, Barrett CJ. Arterial baroreceptor reflex control of renal sympathetic nerve activity following chronic myocardial infarction in male, female, and ovariectomized female rats. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 2015; 309: R169–R178.

[42] Jankowski M, Rachelska G, Donghao W, McCann SM, Gutkowska J. Estrogen receptors activate atrial natriuretic peptide in the rat heart. Proceedings of the National Academy of Sciences of the United States of America. 2001; 98: 11765–11770.

[43] Patten RD, Pourati I, Aronovitz MJ, Alsheikh-Ali A, Eder S, Force T, et al. 17 Beta-estradiol differentially affects left ventricular and cardiomyocyte hypertrophy following myocardial infarction and pressure overload. Journal of Cardiac Failure. 2008; 14: 245–253.

[44] Bianchi PR, Gumz BP, Giuberti K, Stefanon I. Myocardial infarction increases reactivity to phenylephrine in isolated aortic rings of ovariectomized rats. Life Sciences. 2006; 78: 875–881.

[45] Syme C, Shin J, Richer L, Gaudet D, Paus T, Pausova Z. Sex Differences in Blood Pressure Hemodynamics in Middle-Aged Adults with Overweight and Obesity. Hypertension. 2019; 74: 407–412.

[46] Wan S, Vogel MW, Chen HH. Pre-clinical diastolic dysfunction. Journal of the American College of Cardiology. 2014; 63: 407–416.

[47] Palmiero P, Zito A, Maiello M, Cameli M, Modesti PA, Muiesan ML, et al. Left Ventricular Diastolic Function in Hypertension: Methodological Considerations and Clinical Implications. Journal of Clinical Medicine Research. 2015; 7: 137–144.

[48] Tzschätzsch H, Hättasch R, Knebel F, Klaua R, Schultz M, Jenderka K, et al. Isovolumetric elasticity alteration in the human heart detected by in vivo time-harmonic elastography. Ultrasound in Medicine & Biology. 2013; 39: 2272–2278.

[49] Li S, Gupte AA. The Role of Estrogen in Cardiac Metabolism and Diastolic Function. Methodist DeBakey Cardiovascular Journal. 2017; 13: 4–8.

[50] Thawornkaiwong A, Pantharanontaga J, Wattanapermpool J. Hypersensitivity of myofilament response to Ca2+ in association with maladaptation of estrogen-deficient heart under diabetes complication. American Journal of Physiology - Regulatory, Integrative and Comparative Physiology. 2007; 292: R844–R851.

[51] Bupha-Intr T, Oo YW, Wattanapermpool J. Increased myocardial stiffness with maintenance of length-dependent calcium activation by female sex hormones in diabetic rats. American Journal of Physiology - Heart and Circulatory Physiology. 2011; 300: H1661–H1668.

[52] Silberman GA, Fan TM, Liu H, Jiao Z, Xiao HD, Lovelock JD, et al. Uncoupled cardiac nitric oxide synthase mediates diastolic dysfunction. Circulation. 2010; 121: 519–528.

[53] Zhou L, Chen H, Mao X, Qi H, Baker PN, Zhang H. G-protein-coupled receptor 30 mediates the effects of estrogen on endothelial cell tube formation in vitro. International Journal of Molecular Medicine. 2017; 39: 1461–1467.

[54] Menazza S, Murphy E. The Expanding Complexity of Estrogen Receptor Signaling in the Cardiovascular System. Circulation Research. 2016; 118: 994–1007.

[55] Su S, Yang D, Zhu W, Cai Z, Zhang N, Zhao L, et al. Interleukin-17a mediates cardiomyocyte apoptosis through Stat3-iNOS pathway. Biochimica Et Biophysica Acta. 2016; 1863: 2784–2794.

[56] Chen H, Xu Y, Wang J, Zhao W, Ruan H. Baicalin ameliorates isoproterenol-induced acute myocardial infarction through iNOS, inflammation and oxidative stress in rat. International Journal of Clinical and Experimental Pathology. 2015; 8: 10139–10147.

[57] He Q, Zhou W, Xiong C, Tan G, Chen M. Lycopene attenuates inflammation and apoptosis in post-myocardial infarction remodeling by inhibiting the nuclear factor-κB signaling pathway. Molecular Medicine Reports. 2015; 11: 374–378.

[58] Zancan V, Santagati S, Bolego C, Vegeto E, Maggi A, Puglisi L. 17Beta-estradiol decreases nitric oxide synthase II synthesis in vascular smooth muscle cells. Endocrinology. 1999; 140: 2004–2009.

[59] Wang X, Tan Y, Xu B, Lu L, Zhao M, Ma J, et al. GPR30 Attenuates Myocardial Fibrosis in Diabetic Ovariectomized Female Rats: Role of iNOS Signaling. DNA and Cell Biology. 2018; 37: 821–830.

[60] Grover GJ, Atwal KS, Sleph PG, Wang F, Monshizadegan H, Monticello T, et al. Excessive ATP hydrolysis in ischemic myocardium by mitochondrial F1F0-ATPase: effect of selective pharmacological inhibition of mitochondrial ATPase hydrolase activity. American Journal of Physiology-Heart and Circulatory Physiology. 2004; 287: H1747–H1755.

[61] Murphy E, Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiological Reviews. 2008; 88: 581–609.

[62] Perrelli M, Pagliaro P, Penna C. Ischemia/reperfusion injury and cardioprotective mechanisms: Role of mitochondria and reactive oxygen species. World Journal of Cardiology. 2011; 3: 186–200.

[63] Ruiz-Meana M, Abellán A, Miró-Casas E, Garcia-Dorado D. Opening of mitochondrial permeability transition pore induces hypercontracture in Ca2+ overloaded cardiac myocytes. Basic Research in Cardiology. 2007; 102: 542–552.

[64] Feng Y, Madungwe NB, da Cruz Junho CV, Bopassa JC. Activation of G protein-coupled oestrogen receptor 1 at the onset of reperfusion protects the myocardium against ischemia/ reperfusion injury by reducing mitochondrial dysfunction and mitophagy. British Journal of Pharmacology. 2017; 174: 4329–4344.

[65] Luo T, Liu H, Kim JK. Estrogen Protects the Female Heart from Ischemia/Reperfusion Injury through Manganese Superoxide Dismutase Phosphorylation by Mitochondrial p38β at Threonine 79 and Serine 106. PLoS ONE. 2016; 11: e0167761.

[66] Rizzo A, Roscino MT, Minoia G, Trisolini C, Spedicato M, Mutinati M, et al. Serum levels of reactive oxygen species (ROS) in the bitch. Immunopharmacology and Immunotoxicology. 2009; 31: 310–313.

Share and Cite
Diana Ramírez-Hernández, Pedro López-Sanchez, Martha C. Rosales-Hernández, Salvador Fonseca-Coronado, Jazmín Flores-Monroy. Estrous cycle phase affects myocardial infarction through reactive oxygen species and nitric oxide. Frontiers in Bioscience-Landmark. 2021. 26(12); 1434-1443.